Showing results (1261-1270 of 1,373) with videos related to

Sort By:
Pageof 138
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2020
Cancer Antigen Discovery Is Enabled by RNA Sequencing of Highly Purified Malignant and Nonmalignant CellsMartin J Scurr, Alex Greenshields-Watson, Emma Campbell, et al.
Journal of Thrombosis and Haemostasis : JTH|June 16, 2025
Thromboembolism in transplant-ineligible multiple myeloma patients on triplet/quadruplet therapy: a post hoc analysis of BENEFIT trialEmilie Chalayer, Corinne Frere, Elisabeth Daguenet, et al.
Clinical Hematology International|September 22, 2025
Improving Advanced-Line Multiple Myeloma Care: Insights and Real-World Challenges from the EMMY StudyTitouan Cazaubiel, Olivier Decaux, Bruno Royer, et al.
Blood|November 25, 2010
Achievement of VGPR to induction therapy is an important prognostic factor for longer PFS in the IFM 2005-01 trialPhilippe Moreau, Michel Attal, Brigitte Pégourié, et al.
Blood Advances|March 27, 2026
FDG-PET Medullary Total Tumor Volume Highlights High-Risk Newly Diagnosed Multiple Myeloma Patients in CASSIOPEIA TrialJamet Bastien, Shamimeh Ahrari, Sonja Zweegman, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2009
(3,3-Difluoro-pyrrolidin-1-yl)-[(2S,4S)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl]-methanone: a potent, selective, orally active dipeptidyl peptidase IV inhibitorMark J Ammirati, Kim M Andrews, David D Boyer, et al.
The New England Journal of Medicine|May 11, 2012
Lenalidomide maintenance after stem-cell transplantation for multiple myelomaMichel Attal, Valerie Lauwers-Cances, Gerald Marit, et al.
Blood|November 4, 2009
Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myelome (IFM)Murielle Roussel, Philippe Moreau, Anne Huynh, et al.
Physical Review Letters|June 6, 2017
Collimated Propagation of Fast Electron Beams Accelerated by High-Contrast Laser Pulses in Highly Resistive Shocked CarbonX Vaisseau, A Morace, M Touati, et al.
Infectious Diseases and Therapy|February 10, 2023
The Use and Effectiveness of Ceftazidime-Avibactam in Real-World Clinical Practice: EZTEAM StudyAlex Soriano, Philippe Montravers, Matteo Bassetti, et al.
Pageof 138